The role of the skin and gut microbiome in psoriatic disease

D Yan, N Issa, L Afifi, C Jeon, HW Chang… - Current dermatology …, 2017 - Springer
Abstract Purpose of Review To understand the changes in the microbiome in psoriatic
disease, we conducted a systematic review of studies comparing the skin and gut microbiota …

[PDF][PDF] Anogenital human papillomavirus prevalence is unaffected by therapeutic tumour necrosis factor-alpha inhibition.

A Handisurya, S Lázár, P Papay, C Primas… - Acta Dermato …, 2016 - researchgate.net
METHODS This prospective, open, controlled observation study with crosssectional analysis
was approved by the Institutional Review Board of the Medical University of Vienna …

Prevalence of genital and oral human papillomavirus infection among psoriasis patients on biologic therapy

F Rob, J Hugo, M Saláková, J Šmahelová… - Dermatologic …, 2022 - Wiley Online Library
Current knowledge about human papillomavirus (HPV) infection in psoriasis patients treated
with biologics is limited. In this study we evaluated the prevalence of oral and genital HPV …

Prevalence of HPV genital infection in patients with moderate-to-severe psoriasis undergoing systemic treatment with immunosuppressive agents or biologics

A Offidani, G Radi, L Bianchi, SP Cannavò… - European Journal of …, 2021 - Springer
Background Psoriasis is an immune-mediated inflammatory disease and its relationship with
infection has been extensively investigated. Concern for the increased prevalence of human …

Prevalence of human polyomavirus DNA in eyebrow hairs plucked from patients with psoriasis treated with TNF inhibitors.

G Bellaud, T Gheit, A Pugin, JL Pretet… - Journal of the …, 2015 - search.ebscohost.com
Prevalence of human polyomavirus DNA in eyebrow hairs plucked from patients with psoriasis
treated with TNF inhibitors Page 1 LETTERS TO THE EDITOR Contact allergy to chlorphenesin …

Prevalence of anogenital infection by Human Papillomavirus (HPV) in users of immunobiological therapy

EVM Roncada, MOL Carapeba, JE Levi… - Research, Society and …, 2022 - rsdjournal.org
Objective: To compare the prevalence of anogenital infection by human papillomavirus
(HPV) in immunobiological users being treated for immune-mediated chronic inflammatory …

Rôle de l'interleukine-17 dans les infections cutanées induites par les papillomavirus humains

F Brunet-Possenti - 2021 - theses.hal.science
La physiopathologie exacte des manifestations cutanées induites par les papillomavirus
humains (HPV) n'est à ce jour que partiellement élucidée et demeure largement moins bien …

Prevalência da infecção anogenital pelo papilomavírus humano (HPV) em usuários de terapia imunobiológica

EVM RONCADA - 2021 - bdtd.unoeste.br
Prevalência da infecção anogenital pelo papilomavírus humano (HPV) em usuários de
terapia imunobiológica. Introdução: Pacientes usuários de medicamentos imunobiológicos …

Biologická léčba a její vliv na průběh latentních virových infekcí u pacientů s psoriázou

J Laurin - 2019 - dspace.cuni.cz
Existuje přes 80 identifikovaných autoimunitních onemocnění. Mezi ty s nejvyšší prevalencí
patří psoriáza, jejíž celosvětová prevalence se pohybuje okolo 2-5%. Léčebné postupy …